Evotec
Cornelius Eibner has work experience in various roles and organizations. Cornelius is currently the Head of Human Biosample Strategy & Operations at Evotec, starting in October 2021. Prior to this, they worked at the University Hospital Jena from 2018 to 2021 as the Task Force Manager of Network University Medicine (NUM) and as a Project Manager for the Biobank from 2018 to 2020. From 2011 to 2017, they were a Scientific Employee at Friedrich-Schiller University Jena.
Cornelius Eibner completed a Vordiplom in Biologie, allgemein at the University of Hamburg from 1999 to 2002. Cornelius then pursued a Diplombiologe in Biologie, allgemein at The University of Freiburg from 2002 to 2006. Following this, they completed a Diplomarbeit in Biologie, allgemein at the University of Konstanz from 2005 to 2006. Lastly, they obtained a Doctor of Philosophy - PhD in Zoology from the University of Galway from 2006 to 2010.
This person is not in the org chart
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.